The August issue of U.S. magazine Site Selection features an article entitled The Phoenix of Québec: NEOMED brings instant pain relief to life sciences R&D in Greater Montréal
Adam Bruns, the magazine’s Managing Editor, conducted a series of interviews with such industry figures as Max Fehlmann, NEOMED’s President and Chief Executive Officer, and Philippe Walker, the Institute’s Chief Scientific Officer and former Head of AstraZeneca’s R&D centre in Montréal, as well as Dr. Helmut Thomas, President and CEO of Cyclenium Pharma, and Anthony Cheung, President and CEO of enGene.
This is Adam Bruns’ second article this year on Québec’s life-sciences industry. Last June, he published They Want Your Blood: Korea’s Green Cross makes a major investment in Québec
“[...] once you churn, Montréal is probably the best place in Canada.” says Anthony Cheung, President and CEO of Engene, a Vancouver-based pharmaceutical company that recently decided to set up operations at the NEOMED Institute. Site Selection, August 2014
Productivité innovation website (in French only)
Compétivert(in French only)